RxDoctor Payments Data

Eric Lehman, MD

Family Medicine · Archbold, OHNPI 1164464046

Payments from drug & device makers

$879in general payments, 2019–2025

Across 51 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$278
  • Novo Nordisk$107
  • Pfizer$104
  • Exact Sciences$78
  • Novartis$53
  • AstraZeneca$52
  • plus $207 from 10 others

What the payments were for

  • Food & beverage$879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$879 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$139,301
Medicare patients
395
Services billed
3,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban139$114,765
JardianceEmpagliflozin106$88,375
XareltoRivaroxaban29$21,323
JanuviaSitagliptin Phosphate12$16,142
EntrestoSacubitril/Valsartan14$13,323
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$9,919
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,150
MyrbetriqMirabegron13$5,445
SymbicortBudesonide/Formoterol Fumarate12$4,239
Atorvastatin Calcium417$4,086
Metoprolol Succinate187$3,792
Losartan Potassium320$3,330
Advair HfaFluticasone Propion/Salmeterol11$3,125
Verapamil SrVerapamil Hcl12$2,427
Tamsulosin Hcl138$2,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$104$114,765139 claims
Boehringer IngelheimJardiance$17$88,375106 claims
Johnson & JohnsonXarelto$13$21,32329 claims
NovartisEntresto$53$13,32314 claims
GSKTrelegy Ellipta$38$8,15014 claims
AstraZenecaSymbicort$52$4,23912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Archbold

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →